Authored by Marina Zhang via The Epoch Times (emphasis ours),
Compared to Eris, BA.2.86 has a significantly lower growth efficiency, meaning that it is less capable of replicating itself in the human bodies.
The new BA.2.86 variant, unofficially known as Pirola is taking hold in the United States.
Between Oct. 28 to Nov. 25, its prevalence increased from 1 to around 9 percent in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC).
The World Health Organization designated Pirola as a variant of interest on Nov. 21, yet it also found the public health risk posed by BA.2.86 to be "low at the global level (pdf)."